BioSpace News Archive

LiveCare LoRa-based IoT system enables accurate analysis of a cow’s health and milk producing ability

WellCare of New York, Inc., a WellCare Health Plans, Inc. (NYSE: WCG) company, received an overall score of 4 out of 5 in the National Committee for Quality Assurance (NCQA) Medicaid Health Insurance Plan Ratings 2018-2019.

ER Services Remain Open

The Diabetic Foot Global Conference is being held from October 11-13, 2018 in Houston, Texas, USA.

The Howard University College of Medicine will host its 150th Anniversary Gala to Celebrate 150 Years of Excellence in Education, Service and Research, on Friday, November 9, 2018, scheduled 6 p.m. at the Gaylord National Resort and Convention Center, 201 Waterfront Street, National Harbor, MD 20745.

Collaboration to pursue the development of a radioconjugated minigastrin analogue (Debio 1124) for cancer patients.

CEI Vision Partners (CVP), a leading ophthalmology services organization formed by Cincinnati Eye Institute and Revelstoke Capital Partners, announces it has acquired Dayton Eye Associates in Dayton, Ohio.

- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that the company’s Chief Executive Officer Dr. Stuart Titus will speak about Humulus-derived cannabidiol (CBD) at the CBD Outlook Conference on Oct. 16 in Denver.

Grand Rounds, the leader in matching patients with high-quality physicians, and leading health system Intermountain Healthcare, today announced a strategic agreement which will enhance Intermountain’s world-class care through access to in-person visits.

Synthetic Biologics, Inc. (NYSE American: SYN) (“Synthetic Biologics” or the “Company”), a late-stage clinical company focused on developing therapeutics designed to preserve the microbiome to protect and restore the health of patients, announced today the pricing of an underwritten public offering with expected total gross proceeds of $18,000,000 before deducting underwriting discounts, commissions and other offering expenses payable by the Company.